Cresco Labs (CRLBF) Cash from Financing Activities (2019 - 2025)

Cresco Labs (CRLBF) posted Cash from Financing Activities of -$1.8 million for Q4 2025, up 97.48% on a QoQ basis from -$71.1 million in Q3 2025, and up 95.73% year-over-year from -$916037.2 in Q4 2024.

Cresco Labs (CRLBF) Cash from Financing Activities (2019 - 2025) Analysis & Trends

Cresco Labs' Cash from Financing Activities history runs 7 years deep, the most recent figure standing at -$1.8 million for Q4 2025.

  • Quarterly Cash from Financing Activities rose 95.73% year-over-year to -$1.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$117.4 million (down 207.07% YoY) and the FY2025 annual result came in at -$82.1 million, down 14.84% from the prior year.
  • Cash from Financing Activities was -$1.8 million for Q4 2025 at Cresco Labs, up from -$71.1 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $132.2 million in Q1 2021 and bottomed at -$71.1 million in Q3 2025.
  • A 5-year average of $371486.6 and a median of -$3.1 million in 2023 frame the typical range for Cash from Financing Activities.
  • Annual changes were most pronounced in 2021 — Cash from Financing Activities soared 860.8% — and 2025, when it plunged 2785.39%.
  • Cresco Labs' Cash from Financing Activities stood at -$2.4 million in 2021, then advanced by 14.48% to -$2.0 million in 2022, then plunged by 86.21% to -$3.8 million in 2023, then tumbled by 1011.42% to -$42.0 million in 2024, then surged by 95.73% to -$1.8 million in 2025.
  • Business Quant data shows CRLBF's Cash from Financing Activities at -$1.8 million in Q4 2025, -$71.1 million in Q3 2025, and -$42.0 million in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 13.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -840.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -494.13 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -1.48 Bn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -203.80 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -86.10 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -65.00 Mn
10 Cresco Labs 254.96 Mn 99.57 Mn 75.45 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 -1.79 Mn
Dec 31, 2025 -1.79 Mn
Sep 30, 2025 -71.10 Mn
Sep 30, 2025 -71.10 Mn
Dec 31, 2024 -42.03 Mn
Dec 31, 2024 -42.03 Mn
Sep 30, 2024 -2.46 Mn
Sep 30, 2024 -2.46 Mn
Dec 31, 2023 -3.78 Mn
Dec 31, 2023 -3.78 Mn
Sep 30, 2023 10.05 Mn
Sep 30, 2023 10.05 Mn
Dec 31, 2022 -2.03 Mn
Dec 31, 2022 -2.03 Mn
Sep 30, 2022 -9.11 Mn
Sep 30, 2022 -9.11 Mn
Jun 30, 2022 -69.14 Mn
Jun 30, 2022 -69.14 Mn
Mar 31, 2022 -6.37 Mn
Mar 31, 2022 -6.37 Mn